Grown Rogue International (GRUSF) Return on Capital Employed (QoQ) (2011 - 2026)
Grown Rogue International (GRUSF) Return on Capital Employed (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.16 Mn |
| Mar 31, 2026 | -155,904.59 Bn |
| Sep 30, 2024 | -250.00 |
| Jun 30, 2024 | -1,897.00 |
| Apr 30, 2021 | 142,739.00 |
| Jan 31, 2021 | -138,915.00 |
| Oct 31, 2020 | 6,676.00 |
| Jan 31, 2019 | -44,919.00 |
| Nov 30, 2017 | -45,995.00 |
| Aug 31, 2017 | 133,221.00 |
| May 31, 2017 | 15,682.00 |
| Feb 28, 2017 | 31,840.00 |
| Nov 30, 2016 | -182,944.00 |
| May 31, 2015 | 1,004.00 |
| Aug 31, 2014 | -4,708.00 |
| May 31, 2014 | 4,771.00 |
| Aug 31, 2013 | 132.00 |
| Aug 31, 2012 | 86.00 |
| May 31, 2012 | -52.00 |
| Feb 29, 2012 | 38.00 |